Medtronic Stock Forecast

Stock Price Forecast

According to 30 analysts polled by S&P Global, Medtronic stock has a consensus rating of "Buy" and an average price target of $98.58. The average 1-year stock price forecast is 20.71% higher than the current stock price, while the lowest is $78 (-4.49%) and the highest is $121 (+48.16%).

Price Target: $98.58 (+20.71%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$78	$98.58	$100.5	$121
Change	-4.49%	+20.71%	+23.06%	+48.16%

Analyst Ratings

The average analyst rating for Medtronic stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	13	14	14	14	15	15
Buy	3	5	4	4	2	3
Hold	14	13	13	12	13	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	30	32	31	30	30	30

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Roman Goldman Sachs	Goldman Sachs	Hold Maintains $84 → $83	Hold	Maintains	$84 → $83	+1.63%	Jun 5, 2026
Lee Hambright Bernstein	Bernstein	Buy Maintains $112 → $97	Buy	Maintains	$112 → $97	+18.77%	Jun 5, 2026
Vijay Kumar Evercore ISI	Evercore ISI	Buy Maintains $106	Buy	Maintains	$106	+29.79%	Jun 4, 2026
Richard Newitter Truist Financial	Truist Financial	Hold Reiterates $95 → $86	Hold	Reiterates	$95 → $86	+5.30%	Jun 4, 2026
Shagun Singh Chadha RBC Capital	RBC Capital	Buy Reiterates $118	Buy	Reiterates	$118	+44.48%	Jun 4, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

38.17B

from 36.36B

4.96%

from 36.36B

Revenue Next Year

39.77B

from 38.17B

4.19%

from 38.17B

EPS This Year

6.06

from -

EPS Next Year

6.52

from 6.06

7.66%

from 6.06

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 29, 2022	Apr 28, 2023	Apr 26, 2024	Apr 25, 2025	Apr 24, 2026	Apr 30, 2027
Revenue	31.69B	31.23B	32.36B	33.54B	36.36B	38.17B
Revenue Growth	5.21%	-1.45%	3.64%	3.62%	8.43%	4.96%
Gross Profit	21.66B	20.61B	21.27B	21.93B	23.78B	24.97B
Gross Margin	68.35%	65.98%	65.73%	65.39%	65.38%	65.42%
Operating Income	6.85B	5.57B	6.39B	6.40B	7.12B	9.76B
Net Income	5.04B	3.76B	3.68B	4.66B	4.80B	5.87B
EPS	-	-	-	-	-	6.06
Forward PE	18.03	17.32	14.87	14.64	14.29	13.48
Dividend / Share	2.52	2.72	2.76	2.80	2.84	3.01
Dividend Growth	-	7.94%	1.47%	1.45%	1.43%	5.88%
Free Cash Flow	-1.16B	10.06B	5.45B	4.21B	-	6.84B
No. Analysts	-	-	-	-	-	29

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2027	2028	2029
High	39.3B
Avg	38.2B
Low	35.9B

Revenue Growth

Revenue Growth	2027	2028	2029
High	8.1%
Avg	5.0%
Low	-1.3%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	6.06
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	10.4%
Low	-